Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Methallatal

From Wikipedia, the free encyclopedia

Methallatal
Clinical data
Trade namesMosidal
Identifiers
  • 5-ethyl-5-(2-methylprop-2-enyl)-2-sulfanylidene-1,3-diazinane-4,6-dione
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.003.723 Edit this at Wikidata
Chemical and physical data
FormulaC10H14N2O2S
Molar mass226.29 g·mol−1
3D model (JSmol)
  • CCC1(C(=O)NC(=S)NC1=O)CC(=C)C
  • InChI=1S/C10H14N2O2S/c1-4-10(5-6(2)3)7(13)11-9(15)12-8(10)14/h2,4-5H2,1,3H3,(H2,11,12,13,14,15)
  • Key:XMQICEWOKPEQRG-UHFFFAOYSA-N

Methallatal is a barbiturate derivative first synthesized in the 1940s (designation V-12).[1][2] It has sedative and hypnotic properties.

Methallatal was formerly marketed under the trade name Mosidal from 1940s to 1950s for veterinary use, specifically for preventing motion sickness in dogs.[2]

References

[edit]
  1. Carson GB (1954). The barbiturates in forensic chemistry. Ohio State University. Retrieved 2026-02-11.
  2. 1 2 Elliott KA, Noble RL (September 1948). "Control of car sickness in a dog by V-12 (mosidal)". Canadian Medical Association Journal. 59 (3): 277. PMC 1591212. PMID 18877437.